Zalicus Inc.

Epirus Biopharmaceuticals Inc. , a U.S. biotech focused exclusively on biosimilars, is partnering with Polish generics titan Polpharma SA to develop and commercialize biosimilars of three anti-in

Device Transactions During 2014’s third quarter, device firms raised a total of $734 million, less than half of Q2’s $1.6 billion. ( See Exhibit 1. ) The deal activity was pretty evenly spread out amo

IN VITRO DIAGNOSTICS Mergers & Acquisitions Immucor Inc. Organ-I Inc. Immucor Inc. acquired fellow privately held transplant diagnostics company Organ-I Inc. (Jun.) Organ-I spun out of Stanf

IN VITRO DIAGNOSTICS Alliances Abbott Laboratories Inc. Idera Pharmaceuticals Inc. Idera Pharmaceuticals Inc. (toll-like receptor (TLR) antagonists for autoimmune diseases and B-cell lymphomas) si